B Stea
Overview
Explore the profile of B Stea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruno M, Digennaro M, Tommasi S, Stea B, Danese T, Schittulli F, et al.
Eur J Cancer Care (Engl)
. 2009 Nov;
19(3):360-8.
PMID: 19912305
The objective of this study is to evaluate women's awareness and interest in genetic testing for breast cancer risk, to identify socio-demographic factors, to analyse the reasons for wanting or...
2.
Stea B, Shaw E, Pinter T, Hackman J, Craig M, May J, et al.
Br J Cancer
. 2006 Jun;
94(12):1777-84.
PMID: 16773073
Efaproxiral (Efaproxyn, RSR13), a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb-oxygen (O(2)) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy. This analysis evaluated the Phase 3,...
3.
Gadaleta C, Coviello M, Catino A, Venneri M, Stea B, Quaranta M, et al.
J Chemother
. 2005 Jan;
16 Suppl 5:7-10.
PMID: 15675467
Vascular endothelial growth factor (VEGF) is known to play a central role in tumour angiogenesis. However, no data have been published with regard to the clinical-biological significance of serum (S)-VEGF...
4.
Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, et al.
Ann Oncol
. 2004 Jul;
15 Suppl 1:I48-I54.
PMID: 15280188
Background: Before starting a molecular screening program for breast cancer risk and in order to develop ad hoc educational strategies, a population survey in Apulia, Italy, was performed to gather...
5.
Kriederman B, Myloyde T, Bernas M, Preciado S, Lynch M, Stea B, et al.
Lymphology
. 2002 Apr;
35(1):23-7.
PMID: 11939569
Lack of a standardized experimental counterpart of peripheral lymphedema (LE) in a small animal has hampered research into treatment of this debilitating condition. We recently refined a rodent model consisting...
6.
Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, DRACH G, et al.
Cancer
. 2000 Aug;
89(2):399-403.
PMID: 10918172
Background: The current study was conducted to evaluate the combination of external beam radiation therapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Methods: Twenty-six patients...
7.
Anderson J, Stea B, HALLUM A, Rogoff E, CHILDERS J
Int J Radiat Oncol Biol Phys
. 2000 Feb;
46(2):417-25.
PMID: 10661349
Purpose: To evaluate the effectiveness of postoperative high-dose-rate (HDR) vaginal cuff irradiation alone (1500 cGy in 3 fractions) in patients with Stage Ib and Ic endometrial cancer. Methods And Materials:...
8.
Witte M, Bernas M, Witte C, Way D, Stea B
Lymphology
. 1999 Sep;
32(3):111-7.
PMID: 10494523
A reliable, inexpensive experimental counterpart of peripheral lymphedema has been notoriously difficult to reproduce thereby stifling basic and clinical research into this frustrating clinical condition. Accordingly, in 45 adult Wistar-Fuzzy...
9.
Mangia A, De Lena M, Barletta A, Marzullo F, Attolico M, Stea B, et al.
J Exp Clin Cancer Res
. 1999 Jan;
17(3):317-23.
PMID: 9894769
We verified the variations of primary tumour steroid receptor status and proliferative activity at different times and phases (follicular vs luteal) of the menstrual cycle and their relationship with short...
10.
Gannett D, Hill D, Hamilton A, Stea B
Am J Clin Oncol
. 1997 Jun;
20(3):233-6.
PMID: 9167743
This report describes the treatment of a 39-year-old man with recurrent medulloblastoma previously treated with extensive chemotherapy and radiation therapy. A novel treatment technique combining paclitaxel (275 mg IV bolus)...